AJJARAPU SURENDRA K 4/A

What Happened

• Director AJJARAPU SURENDRA K received compensation from Wellgistics Health (WGRX) on March 31, 2026 in the form of 5,000,000 common shares at $0.20 per share (total value reported $1,000,000) and 5,000,000 warrants (reported as a derivative award valued at $500). Both grants are reported with transaction code A (award/grant).

Key Details

• Transaction date: 2026-03-31; Shares: 5,000,000 at $0.20 (total $1,000,000); Warrants: 5,000,000 reported as derivative award (value reported $500).
• Shares/warrants were issued as compensation and were exempt from registration under Section 4(a)(2) of the Securities Act (see footnotes F1 and F2).
• Filing type: Amended Form 4 filed 2026-06-25 covering the Mar 31, 2026 grants (this is an amendment to the originally reported transaction).
• Shares owned after the transaction: Not specified in the amended filing.
• Transaction code: A = Award/Grant. These are not open-market purchases or sales.

Context

• These transactions are compensation awards to an insider rather than purchases (which some investors interpret as a bullish signal) or sales (which can indicate liquidity needs). Warrants are derivatives that give the holder the right to buy stock later; exercise terms were not provided in the filing.
• Both issuances were made in private transactions exempt from registration under Section 4(a)(2), per the filing footnotes.